CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc.

2.14
USD
-0.21
(-8.94%)
-0.44EPS
817.12MMarket Cap
Nov 05Next Earn

CytomX Therapeutics, Inc. Documents

Q4 FY2025 · Presentation

Varseta-M Phase 1 Interim Dose Expansion_Data_For_Webcast · 26 pages

Read CytomX Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents